Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00974922 · ClinicalTrials.gov registry record · Phase 4
Vitamin D Deficiency in Patients With Hypertension
A Phase 4 study, sponsored by UConn Health.
- Terminated
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT00974922 is a Phase 4 study that was terminated before completion, run by UConn Health. The registered enrollment target is 40 participants.
The verdict
NCT00974922, a Phase 4 study, was terminated before completion, sponsored by UConn Health.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
This study will evaluate the effects of Vitamin D replacement and the effects of an approved medication for hypertension, aliskiren (Tekturna), in patients with high blood pressure who have low levels of vitamin D in their blood. The study will compare the effects of vitamin D or aliskiren alone and in combination on 24-hour blood pressure and biochemical parameters.
Interventions
- DIETARY_SUPPLEMENT Cholecalciferol
- DIETARY_SUPPLEMENT Placebo
- DRUG Aliskiren
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2009-08 |
| Est. Completion | 2011-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00974922
The ClinicalTrials.gov registry entry for NCT00974922 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UConn Health, which has 178 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Cholecalciferol is the first listed.
NCT00974922 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00974922 about?
NCT00974922 is a clinical study titled "Vitamin D Deficiency in Patients With Hypertension". This study will evaluate the effects of Vitamin D replacement and the effects of an approved medication for hypertension, aliskiren (Tekturna), in patients with high blood pressure who have low levels of vitamin D in their blood. The study will compare the effects of vitamin D or aliskiren alone and...
What is the current status of trial NCT00974922?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2009-08. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00974922?
The interventions under investigation include: Cholecalciferol (DIETARY_SUPPLEMENT), Placebo (DIETARY_SUPPLEMENT), Aliskiren (DRUG).
Who is sponsoring clinical trial NCT00974922?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.